Clinical Trial Update: Study of the Effect of FLUTTER® VRP1 (PEP and Oscillating High Frequency). [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating FLUTTER VRP1 for bronchiectasis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiectasis

Drugs mentioned

• FLUTTER VRP1 (PEP and Oscillating High Frequency)

Snippet

Sponsor: University of Sao Paulo | Conditions: Bronchiectasis | Phase 1 | Status: TERMINATED